Cargando…

Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass

Case series Patients: Male, 71-year-old • Male, 71-year-old Final Diagnosis: Vasoplegic syndrome Symptoms: Refractory hypotension Medication: — Clinical Procedure: Cardiopulmonary bypass Specialty: Anesthesiology OBJECTIVE: Unusual or unexpected effect of treatment BACKGROUND: Cardiac vasoplegic syn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peyko, Vincent, Finamore, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218885/ https://www.ncbi.nlm.nih.gov/pubmed/34143764 http://dx.doi.org/10.12659/AJCR.930890

Ejemplares similares

The Use of Intravenous Hydroxocobalamin as a Rescue in Methylene Blue-resistant Vasoplegic Syndrome in Cardiac Surgery
por: Cai, Yi, et al.
Publicado: (2017)

Methylene Blue For Post-Cardioplumonary Bypass Vasoplegic Syndrome
por: Pangasa, Neha, et al.
Publicado: (2017)

Methylene Blue for Postcardiopulmonary Bypass Vasoplegic Syndrome: A Cohort Study
por: Mazzeffi, Michael, et al.
Publicado: (2017)

Methylene Blue for Vasoplegic Syndrome Postcardiac Surgery
por: Habib, Aly Makram, et al.
Publicado: (2018)

The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients
por: Ayers, Brian, et al.
Publicado: (2020)

Extended Duration Infusion of Hydroxocobalamin for Vasoplegic Rescue in Septic Shock
por: Gerdes, Harrison J, et al.
Publicado: (2021)

High-dose hydroxocobalamin for vasoplegic syndrome causing false blood leak alarm
por: Cheungpasitporn, Wisit, et al.
Publicado: (2017)

Severe Undifferentiated Vasoplegic Shock Refractory to Vasoactive Agents Treated with Methylene Blue
por: Manji, Farheen, et al.
Publicado: (2017)

Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised
por: Evora, Paulo Roberto Barbosa, et al.
Publicado: (2015)

Vasoplegic Syndrome after Cardiopulmonary Bypass in Cardiovascular Surgery: Pathophysiology and Management in Critical Care
por: Ltaief, Zied, et al.
Publicado: (2022)

The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery
por: Petermichl, Walter, et al.
Publicado: (2021)

The Durability of Intravenous Hydroxocobalamin in Vasoplegia
por: Blaha, Madeline, et al.
Publicado: (2023)

Dermal tattooing following intravenous methylene blue for refractory hypotension after coronary artery bypass grafting
por: Bhatt, Amar M., et al.
Publicado: (2017)

Use of methylene blue in vasoplegic syndrome that developed during non-cardiac surgery - A case report -
por: Oh, In Duk, et al.
Publicado: (2019)

Methylene blue as treatment for vasoplegic shock in severe metformin overdose: A case report
por: Workum, Jessica D., et al.
Publicado: (2023)

Role of plasminogen activator inhibitor-1 polymorphism on the development of vasoplegic syndrome associated with cardiopulmonary bypass
por: Jimenez, J, et al.
Publicado: (2007)

Vasoplegic Syndrome Post-cardiopulmonary Bypass in a Renal Transplant Patient: The Brain Is Not the Index Organ
por: Bennett, Sean R, et al.
Publicado: (2022)

Early Use of Methylene Blue in Vasoplegic Syndrome: A 10-Year Propensity Score-Matched Cohort Study
por: Kofler, Othmar, et al.
Publicado: (2022)

Cardiopulmonary bypass increases the risk of vasoplegic syndrome after coronary artery bypass grafting in patients with dialysis-dependent chronic renal failure
por: Hossne Junior, Nelson Américo, et al.
Publicado: (2015)

Vasoplegic syndrome after cardiopulmonary bypass surgery – associated factors and clinical outcomes: a nested case-control study
por: Iribarren, J, et al.
Publicado: (2007)

After Thirty Years, We Still Cannot Understand Why Methylene Blue is not a Reference to Treat Vasoplegic Syndrome in Cardiac Surgery
por: Evora, Paulo Roberto B., et al.
Publicado: (2021)

Successful treatment of intravenous drug abuser with refractory vasoplegic syndrome after mitral valve repair for infective endocarditis
por: Lambert, Jacob, et al.
Publicado: (2021)

Intravenous infusion of angiotensin II for treatment of cardiopulmonary bypass-induced vasoplegic shock after implantation of left ventricular assist device: a case report
por: Šribar, Andrej, et al.
Publicado: (2023)

Methylene Blue in Refractory Shock
por: Chalise, Som N, et al.
Publicado: (2022)

Altered kinetics of circulating progenitor cells in cardiopulmonary bypass (CPB) associated vasoplegic patients: A pilot study
por: Nandi, Sanhita, et al.
Publicado: (2020)

Hydroxocobalamin in Refractory Septic Shock: A Retrospective Case Series
por: Sacco, Alicia J., et al.
Publicado: (2021)

High-Dose Hydroxocobalamin for Refractory Vasoplegia Post Cardiac Surgery
por: Bak, Marek A, et al.
Publicado: (2022)

METHYLENE BLUE IN REFRACTORY SEPTIC SHOCK
por: Eliliwi, Mouhanned, et al.
Publicado: (2020)

Why Methylene Blue Is the Only Option for Blocking the cGMP/NO Pathway in The Treatment of Vasoplegic Shock? “Reasons That Reason Itself Does Not Know...”
por: Evora, Paulo Roberto B., et al.
Publicado: (2021)

Vasoplegic Syndrome after Cardiac Surgery for Infective Endocarditis
por: Lim, Pascal, et al.
Publicado: (2022)

Locked-in Syndrome and Blue Toe Syndrome Caused by Cardiopulmonary Bypass
por: Sabzi, Feridoun, et al.
Publicado: (2010)

Hydroxocobalamin as Rescue Therapy in a Patient With Refractory Amlodipine-Induced Vasoplegia
por: Ayasa, Laith A, et al.
Publicado: (2023)

Refractory Vasoplegic Syndrome in an Adult Patient with Infective Endocarditis: A Case Report and Literature Review
por: Mirhosseini, Seyed Mohsen, et al.
Publicado: (2017)

Rescue of Nimodipine-Induced Refractory Vasoplegia With Hydroxocobalamin in Subarachnoid Hemorrhage: A Case Report
por: Clifford, Katherine M., et al.
Publicado: (2020)

Complexities of Characterizing “Vasoplegics”
por: Niyogi, Subhrashis Guha, et al.
Publicado: (2023)

Can Use of Intravenous Methylene Blue Improve the Hemodynamics and Outcome of the Patients with Refractory Septic Shock? An Observational Study
por: Rajbanshi, Lalit Kumar, et al.
Publicado: (2023)

Efficacy of intravenous methylene blue, intravenous artesunate, and their combination in preclinical models of malaria
por: Ohrt, Colin, et al.
Publicado: (2014)

Vasoplegic syndrome in patients undergoing heart transplantation
por: Qin, Tong-xin, et al.
Publicado: (2023)

Vasoplegic Syndrome and Anaesthesia: A Narrative Review
por: Gökdemir, Begüm Nemika, et al.
Publicado: (2023)

Hydroxocobalamin as a Cause of Oxalate Nephropathy
por: Legrand, Matthieu
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0k6lnf9tempb82uekgj9rfll9m